Prevalence and prognosis of paroxysmal nocturnal haemoglobinurea and the clinical and cost-effectiveness of eculizumab.  Report number 69,2008

W Connock; Dechao Wang; Anne Fry-Smith; David Moore

Prevalence and prognosis of paroxysmal nocturnal haemoglobinurea and the clinical and cost-effectiveness of eculizumab. Report number 69,2008

W Connock, Dechao Wang, Anne Fry-Smith, David Moore

Research output: Book/Report › Commissioned report

Original language	English
Publisher	Not Known
ISBN (Print)	9780704426948
Publication status	Published - 1 Jan 2008

Bibliographical note

Department of Public health and Epidemiology. University of Birmingham

Cite this

@book{ed4dc763e4ac470c887896087126590e,

title = "Prevalence and prognosis of paroxysmal nocturnal haemoglobinurea and the clinical and cost-effectiveness of eculizumab. Report number 69,2008",

author = "W Connock and Dechao Wang and Anne Fry-Smith and David Moore",

note = "Department of Public health and Epidemiology. University of Birmingham",

year = "2008",

month = jan,

day = "1",

language = "English",

isbn = "9780704426948",

publisher = "Not Known",

}

TY - BOOK

T1 - Prevalence and prognosis of paroxysmal nocturnal haemoglobinurea and the clinical and cost-effectiveness of eculizumab. Report number 69,2008

AU - Connock, W

AU - Wang, Dechao

AU - Fry-Smith, Anne

AU - Moore, David

N1 - Department of Public health and Epidemiology. University of Birmingham

PY - 2008/1/1

Y1 - 2008/1/1

M3 - Commissioned report

SN - 9780704426948

BT - Prevalence and prognosis of paroxysmal nocturnal haemoglobinurea and the clinical and cost-effectiveness of eculizumab. Report number 69,2008

PB - Not Known

ER -